C-FWMBAHNP Precision Health
precision medicine, cognitive decline, p-Tau 217
clinical care
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-FWMB
C-FWMBC-FWMBprecision medicine, cognitive decline, p-Tau 217
0-100 chain-logic scale · 15 dimensions · scored on public evidence
AHNP states that Alzheimer’s is not an inevitable destiny and is not only preventable but reversible. It presents Dr. Dale Bredesen’s research as having changed the understanding of Alzheimer’s disease and claims that AHNP operationalized his findings into a Bredesen-approved, personalized protocol that identifies the sources and subtype of cognitive decline and provides step-by-step interventions to prevent or reverse SCI, MCI, and early-stage Alzheimer’s disease.
SourceAHNP states that cognitive decline, Alzheimer's disease, and type 2 diabetes can be prevented and, in some cases, reversed through an integrated precision-health approach combining genetic, blood and biomarker, and behavioral testing with education, technology, coaching, and physician-guided protocols. The company says these protocols are based on decades of research and process refinement, and expresses the belief that its ReCODE-based system can identify subtypes of cognitive decline and enable unprecedented success in preventing and reversing that decline.
Source